Brain Canada   Report issue

Foundation Phase 2 Phase 3
Founded: Montréal Canada (1998)

Organization Overview

First Clinical Trial
2015
NCT02315443
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Brain Canada